Skip to main content
logo
Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
5.81
-0.16 (-2.60%)
At close: Jun 18, 2026, 4:00 PM EDT
5.82
+0.02 (0.26%)
After-hours: Jun 18, 2026, 7:46 PM EDT

Vanda Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
349521279243420877
Market Cap Growth
33.28%86.63%15.04%-42.14%-52.16%21.66%
Enterprise Value
159.55264.5-87.25-138.46-38.41454.33
Last Close Price
5.818.824.794.227.3915.69
PE Ratio
---105.5067.1827.05
Forward PE
----21.7421.94
PS Ratio
1.602.411.411.261.653.26
PB Ratio
1.241.590.520.450.801.74
P/TBV Ratio
2.072.470.660.570.831.84
P/FCF Ratio
---19.5513.4013.78
P/OCF Ratio
---18.9713.1213.66
EV/Sales Ratio
0.731.22-0.44-0.72-0.151.69
EV/EBITDA Ratio
--2.8314.40-10.09
EV/EBIT Ratio
--2.159.92-10.78
EV/FCF Ratio
--5.37--7.14
Debt / Equity Ratio
0.030.020.020.010.020.02
Debt / EBITDA Ratio
----0.970.22
Debt / FCF Ratio
---0.560.280.16
Net Debt / Equity Ratio
-0.69-0.78-0.68-0.70-0.87-0.84
Net Debt / EBITDA Ratio
1.301.8411.8839.64-50.55-9.39
Net Debt / FCF Ratio
1.532.3322.56-30.70-14.63-6.64
Asset Turnover
0.470.380.300.300.410.48
Inventory Turnover
7.147.297.3411.6021.8922.24
Quick Ratio
1.912.194.224.825.476.25
Current Ratio
2.162.394.394.945.686.43
Return on Equity (ROE)
-78.80%-50.93%-3.49%0.47%1.22%6.92%
Return on Assets (ROA)
-55.63%-41.98%-5.14%-0.86%0.57%5.85%
Return on Invested Capital (ROIC)
-118.29%-96.78%-12.35%-2.60%2.22%21.00%
Return on Capital Employed (ROCE)
-49.98%-33.59%-7.28%-2.53%1.19%8.54%
Earnings Yield
---0.95%1.49%3.70%
FCF Yield
---5.11%7.46%7.26%
Buyback Yield / Dilution
-1.41%-1.34%-1.03%-1.01%-0.11%-3.14%
Total Shareholder Return
-1.41%-1.34%-1.03%-1.01%-0.11%-3.14%
SEC Filings: 10-K · 10-Q